See every side of every news story
Published loading...Updated

With Cancer, She Shouts Her Anger After the Passing of the Duplomb Law

Summary by 20 Minutes
On Tuesday, Fleur Breteau, a cancer patient, shouted his anger at the National Assembly at the deputies who voted for the adoption of the Duplomb law

5 Articles

All
Left
1
Center
1
Right
Center

On Tuesday, Fleur Breteau, a cancer patient, shouted his anger at the National Assembly at the deputies who voted for the adoption of the Duplomb law

·France
Read Full Article
Left

Fleur Breteau, founder of the group Cancer Anger, won the hemicycle against the adoption of this text which provides for the derogatory reintroduction of acetamipride.

·Paris, France
Read Full Article

On Tuesday 8 July 2025, the National Assembly finally adopted the proposal for a law on agriculture which includes, in other words, the reintroduction under conditions of a neonicotinoid pesticide. A hard blow for associations to fight cancer.

Read Full Article

Forbidden in France, authorised until 2033 elsewhere in Europe, neonicotinoids, health risks, political opposition... On Tuesday 9 July, the National Assembly voted the bill Duplomb by 316 votes to 223, reinvigorating the debate on the... Read more about Elle.fr

Read Full Article

Fleur Breteau denounces the Duplomb law, a controversial text on pesticides. Discover its poignant fight for public health and the environment.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Le Huffington Post broke the news in Paris, France on Tuesday, July 8, 2025.
Sources are mostly out of (0)

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.